Conservative Management of Rectourethral Fistula
A monitored trial of drainage and supportive care is reasonable for selected small rectourethral fistulas (RUFs) in viable, nonirradiated tissue. Control contamination and infection first; do not promise spontaneous closure. Chronic, epithelialized, irradiated or tissue-destructive fistulas usually require reconstruction or a diversion strategy.[1][2]
For surgical alternatives see Transperineal Approach to RUF, York-Mason Repair, ERAF for RUF, and Transanal Minimally Invasive Repair. See Fecal Diversion for stoma selection and reversal planning.
What “conservative” means
The literature sometimes groups all treatment without direct fistula closure as conservative management. That can include suprapubic cystostomy, nephrostomy or an intestinal stoma; these are procedures, not observation alone. Distinguish three goals:[2][3]
- Attempt closure: dependable urinary drainage with reassessment in an appropriate simple fistula.
- Prepare for repair: control contamination, drain collections and let injured tissue recover; temporary urinary and/or fecal diversion may be needed.
- Long-term symptom control: accept a persistent tract when reconstruction is unsuitable or declined, with an explicit plan for infection, pain, leakage and drainage.
A 2026 systematic review of 34 studies and 455 post-prostatectomy RUF cases found heterogeneous management and generally less than 50% success where conservative treatment was attempted. Its one-month median urinary-catheter and three-month median stoma durations describe reported practice; they are not evidence that everyone should wait that long.[1]
Initial assessment and source control
Assess fistula anatomy, urethral patency, bladder and bowel function, prior radiation/ablation, necrosis, abscess and malignancy. Cystourethroscopy, rectal examination/endoscopy and urethrography define the communication; cross-sectional imaging helps when collections or complex disease are suspected. Baseline continence matters because closing a tract may uncover substantial SUI.[2][4]
Sepsis, an undrained abscess, peritonitis, uncontrolled pain or ineffective urinary drainage requires prompt treatment rather than a waiting-period algorithm. Use antibiotics for infection and obtain source control with drainage/diversion as indicated. Provide skin care, nutrition, hydration and catheter support while the definitive plan is developed.[2][4]
| Clinical situation | Reasonable direction |
|---|---|
| Small, recent fistula; viable tissue; symptoms controlled; no undrained infection | Consider urinary drainage and close follow-up after specialist assessment |
| Fecaluria or substantial fecal contamination | Assess urgently for infection and the need for fecal diversion; this strongly favors diversion in many patients |
| Large defect, ischemic/radiated tissue, stricture or persistent epithelialized tract | Plan reconstruction or durable diversion early; prolonged catheterization has a low likelihood of definitive closure |
| Patient declines repair or cannot tolerate it | Agree on a symptom-focused plan and escalation triggers; ongoing surveillance is still necessary |
Fecaluria is a serious selection factor, not a universally validated stand-alone rule. Thomas's recommendation for colostomy arose from 13 post-prostatectomy cases: three selected patients without fecaluria healed with conservative treatment, while one attempted immediate repair without colostomy in the presence of fecaluria failed. These observations cannot guarantee 100% success without fecaluria or determine treatment from that symptom alone.[5]
What the reported closure rates actually mean
| Study | Results | Limits |
|---|---|---|
| Thomas 2010 | 3/3 selected patients healed without colostomy; 3/9 healed after colostomy plus urethral catheterization | Tiny, nonrandomized groups selected by presentation.[5] |
| Keller 2015 | 14/30 healed without definitive fistula surgery: eight without fecal diversion and six following diversion | The 27% and 20% figures both use all 30 patients as denominator. They are not the success rates of the nondiverted and diverted strategies.[3] |
| al-Ali 1997 | 14/30 healed after colostomy plus suprapubic cystostomy | Posttraumatic cohort, mostly missile injuries; not a contemporary radiation-fistula cohort.[6] |
| Serra-Aracil 2018 | 1/10 healed with bladder catheterization alone; 1/9 remaining patients healed after urinary and fecal exclusion | Most still needed repair despite diversion.[7] |
Keller's overall 90% healing included subsequent operations; it is not a conservative-treatment success rate. Fifteen of 20 diverted patients eventually had stoma closure, while 11/30 had long-term urinary incontinence and six required permanent urinary diversion or drainage. Fistula closure, urinary function and freedom from stomas are separate outcomes.[3]
Reassessment and timing of reconstruction
There is no validated universal three-to-six-month trial. Chen's review suggests reconsidering repair when a simple tract persists beyond roughly 12 weeks; Boushey's historical two-patient report proposed three to six months of diversion. These are practice frameworks, not competing randomized timing protocols.[2][8]
Set a planned reassessment and move earlier when drainage fails, symptoms worsen, infection persists or the anatomy makes spontaneous closure implausible. A delay for tissue recovery before reconstruction has a different purpose from expecting a chronic tract to seal. Gupta's 15-patient series delayed reconstruction at least 12 weeks after bowel diversion, but included congenital and traumatic cases as well as iatrogenic fistulas.[9]
Adjuncts do not replace definitive management
Sealants and endoscopic treatment. Wilbert's two successful cases combined excision, suturing, fulguration and fibrin application. Giuliani's four closures in five patients followed direct transperineal repair with a TachoSil patch. Neither isolates a sealant effect or represents nonoperative treatment. Evans's 18/19 successful outcomes combined urinary injuries, complications and five fistulas; 94.7% is not an RUF sealant cure rate.[10][11][12]
Endoscopic obliteration of congenital remnant tracts/prostatic utricles is a different problem from an acquired adult RUF. Similarly, ASCRS statements about glue for fistula-in-ano should not be presented as direct RUF trial evidence.
Hyperbaric oxygen. Four men who received HBOT in Marguet's six-case radiation-RUF series did not achieve healing with it. Hammad's 2026 matched study involved perianal, rectovaginal and pouch-vaginal fistulas, not RUF: overall healing was not significantly different, although selected recurrence/subgroup outcomes favored HBOT. It does not establish HBOT efficacy for RUF. An adjunctive role in radiation tissue injury requires specialist judgment and should not delay needed drainage or repair.[13][14]
Durable diversion and symptom-focused care
Radiation/ablation history warrants early discussion of reconstructive burden, but it does not make permanent dual diversion inevitable. Linder's severe referral cohort had permanent urinary diversion in 27/29 and colostomy in 25/29 radiation/ablation cases. By contrast, Vanni reported single-stage closure in 84% of 39 radiation/ablation fistulas treated with transperineal reconstruction, with permanent fecal diversion in 31%. Different selection and functional endpoints explain why these percentages must not be combined into one prognosis.[15][16]
Martins reported permanent dual diversion in 5/10 radiation/ablation patients versus 0/13 surgery-only patients. All 23 initially received colostomy and suprapubic drainage. Their severe, small cohort supports discussing permanent diversion when tissue destruction or organ dysfunction makes reconstruction burdensome; it does not prove that all radiation fistulas require it.[4]
Venkatesan described three patients who chose continued conservative care after being offered surgery. Their persistent complex fistulas required monitoring and episodic symptom treatment. This is an informed quality-of-life option, not evidence of spontaneous cure or freedom from future complications.[17]
Preventing progression after rectal injury
Recognizing and repairing a rectal injury during prostatectomy is distinct from treating an established RUF. Roberts reported 16 injuries recognized and primarily repaired, with two later fistulas; four had omental interposition and none developed RUF. That uncontrolled subgroup does not establish 100% preventive efficacy of omentum. Delayed recognition requires prompt assessment for leak and sepsis.[18]
References
1. de Angelis M, Scilipoti P, Leni R, et al. "Clinical and surgical management of recto-urinary fistula after radical prostatectomy: a systematic review on current evidence." Prostate Cancer Prostatic Dis. 2026. doi:10.1038/s41391-026-01114-7
2. Chen S, Gao R, Li H, Wang K. "Management of acquired rectourethral fistulas in adults." Asian J Urol. 2018;5(3):149–154. doi:10.1016/j.ajur.2018.01.003
3. Keller DS, Aboseif SR, Lesser T, et al. "Algorithm-based multidisciplinary treatment approach for rectourethral fistula." Int J Colorectal Dis. 2015;30(5):631–638. doi:10.1007/s00384-015-2183-0
4. Martins FE, Felicio J, Oliveira TR, et al. "Adverse features of rectourethral fistula requiring extirpative surgery and permanent dual diversion: our experience and recommendations." J Clin Med. 2021;10(17):4014. doi:10.3390/jcm10174014
5. Thomas C, Jones J, Jäger W, et al. "Incidence, clinical symptoms and management of rectourethral fistulas after radical prostatectomy." J Urol. 2010;183(2):608–612. doi:10.1016/j.juro.2009.10.020
6. al-Ali M, Kashmoula D, Saoud IJ. "Experience with 30 posttraumatic rectourethral fistulas: presentation of posterior transsphincteric anterior rectal wall advancement." J Urol. 1997;158(2):421–424. doi:10.1016/s0022-5347(01)64493-8
7. Serra-Aracil X, Labró-Ciurans M, Mora-López L, et al. "The place of transanal endoscopic surgery in the treatment of rectourethral fistula." Urology. 2018;111:139–144. doi:10.1016/j.urology.2017.08.049
8. Boushey RP, McLeod RS, Cohen Z. "Surgical management of acquired rectourethral fistula, emphasizing the posterior approach." Can J Surg. 1998;41(3):241–244. PubMed.
9. Gupta G, Kumar S, Kekre NS, Gopalakrishnan G. "Surgical management of rectourethral fistula." Urology. 2008;71(2):267–271. doi:10.1016/j.urology.2007.10.042
10. Wilbert DM, Buess G, Bichler KH. "Combined endoscopic closure of rectourethral fistula." J Urol. 1996;155(1):256–258. PubMed.
11. Giuliani G, Guerra F, Coletta D, et al. "Repair of transperineal recto-urethral fistula using a fibrin sealant haemostatic patch." Colorectal Dis. 2016;18(11):O432–O435. doi:10.1111/codi.13518
12. Evans LA, Ferguson KH, Foley JP, Rozanski TA, Morey AF. "Fibrin sealant for the management of genitourinary injuries, fistulas and surgical complications." J Urol. 2003;169(4):1360–1362. doi:10.1097/01.ju.0000052663.84060.ea
13. Marguet C, Raj GV, Brashears JH, et al. "Rectourethral fistula after combination radiotherapy for prostate cancer." Urology. 2007;69(5):898–901. doi:10.1016/j.urology.2007.01.044
14. Hammad AF, Erkaya M, Hull TL, et al. "Impact of hyperbaric oxygen therapy on complex perineal fistula healing." Colorectal Dis. 2026;28(3):e70398. doi:10.1111/codi.70398
15. Linder BJ, Umbreit EC, Larson D, et al. "Effect of prior radiotherapy and ablative therapy on surgical outcomes for the treatment of rectourethral fistulas." J Urol. 2013;190(4):1287–1291. doi:10.1016/j.juro.2013.03.077
16. Vanni AJ, Buckley JC, Zinman LN. "Management of surgical and radiation-induced rectourethral fistulas with an interposition muscle flap and selective buccal mucosal onlay graft." J Urol. 2010;184(6):2400–2404. doi:10.1016/j.juro.2010.08.004
17. Venkatesan K, Zacharakis E, Andrich DE, Mundy AR. "Conservative management of urorectal fistulae." Urology. 2013;81(6):1352–1356. doi:10.1016/j.urology.2012.10.040
18. Roberts WB, Tseng K, Walsh PC, Han M. "Critical appraisal of management of rectal injury during radical prostatectomy." Urology. 2010;76(5):1088–1091. doi:10.1016/j.urology.2010.03.054